BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per Share
BioLife Solutions entered into a definitive Agreement and Plan of Merger with Repligen under which Repligen will acquire all outstanding BioLife shares for $11.25 in cash plus 0.1442 shares of Repligen common stock per BioLife share. The two-step merger will make BioLife a wholly owned subsidiary o…